1-2 of 2
Yury N. Fedotov, MD,PhD
Close
Sort by
Journal Articles

Multicenter Experience of High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT) in Multiple Sclerosis (MS) Patients.

Yury L. Shevchenko, Andrei A. Novik, Alexey N. Kuznetcov, Boris V. Afanasiev, Igor A. Lisukov, Oleg A. Rykavicin, Alexandr A. Myasnikov, Tatiana I. Ionova, PhD, Sergey V. Shamanski, MD,PhD, Andrey D. Kulagin, MD,PhD, Olga A. Malysheva, MD, Nikolay I. Baziy, MD,PhD, Vladimir Y. Melnichenko, MD,PhD, Denis A. Fedorenko, MD,PhD, Inna V. Vereschagina, MD, Andrey E. Zdorov, MD, Anton V. Kishtovich, PhD, Roman A. Ivanov, PhD, Yury N. Fedotov, MD,PhD, Gary I. Gorodokin, MD
Journal: Blood
Blood (2006) 108 (11): 3072.
https://doi.org/10.1182/blood.V108.11.3072.3072
Published: 2006
Journal Articles

Treatment Outcomes in Multiple Sclerosis (MS) Patients after Early, Conventional and Salvage High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT).

Yury L. Shevchenko, Andrei A. Novik, Boris V. Afanasiev, Igor A. Lisukov, Tatiana I. Ionova, PhD, Andrei D. Kulagin, MD, Olga A. Malysheva, MD, Gennady N. Bisaga, MD, PhD, Vladimir J. Melnichenko, MD, PhD, Sergei V. Voloshin, MD, PhD, Denis A. Fedorenko, MD, PhD, Inna V. Vereschagina, MD, Anton V. Kishtovich, PhD, Yury N. Fedotov, MD, PhD, Gary I. Gorodokin, MD
Journal: Blood
Blood (2005) 106 (11): 5467.
https://doi.org/10.1182/blood.V106.11.5467.5467
Published: 2005